StockNews.com assumed coverage on shares of Aspira Women’s Health (NASDAQ:AWH – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the stock.
Aspira Women’s Health Stock Performance
AWH stock opened at $0.75 on Friday. The stock has a fifty day moving average of $0.83 and a 200-day moving average of $1.12. Aspira Women’s Health has a fifty-two week low of $0.67 and a fifty-two week high of $5.65. The company has a market capitalization of $12.50 million, a price-to-earnings ratio of -0.62 and a beta of 1.39.
Hedge Funds Weigh In On Aspira Women’s Health
A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. lifted its position in Aspira Women’s Health Inc. (NASDAQ:AWH – Free Report) by 33.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 316,294 shares of the company’s stock after purchasing an additional 79,898 shares during the quarter. B. Riley Wealth Advisors Inc. owned about 1.90% of Aspira Women’s Health worth $256,000 at the end of the most recent quarter. 12.19% of the stock is currently owned by hedge funds and other institutional investors.
Aspira Women’s Health Company Profile
Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.
Further Reading
- Five stocks we like better than Aspira Women’s Health
- ETF Screener: Uses and Step-by-Step Guide
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- What is the Nikkei 225 index?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.
